Suma Ramadas, PhDMedical Affairs
Matthew DurhamOmnidynamic Marketing
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Bud BilanichSuccess Coach
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
SEATTLE, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical ...
-- Met primary endpoint of safety and tolerability -- -- A dose-dependent reduction of ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email